Future cardiology最新文献

筛选
英文 中文
Recent advances and translational challenges of potassium channel openers in cardiovascular medicine: a narrative review. 心血管医学中钾通道打开剂的最新进展和转化挑战:叙述性综述。
IF 1.1
Future cardiology Pub Date : 2026-11-16 DOI: 10.1080/14796678.2026.2761840
Sasan Shafiei, Zahra Nemati, Alireza Arzhangzadeh, Ali Parouhan, Mohammadesmaeil Aramesh Boroujeni, Rezvan Alizade, Armina Torabian, Salma Nozhat, Amin Zaki Zadeh, Amin Sedokani
{"title":"Recent advances and translational challenges of potassium channel openers in cardiovascular medicine: a narrative review.","authors":"Sasan Shafiei, Zahra Nemati, Alireza Arzhangzadeh, Ali Parouhan, Mohammadesmaeil Aramesh Boroujeni, Rezvan Alizade, Armina Torabian, Salma Nozhat, Amin Zaki Zadeh, Amin Sedokani","doi":"10.1080/14796678.2026.2761840","DOIUrl":"https://doi.org/10.1080/14796678.2026.2761840","url":null,"abstract":"<p><p>Cardiovascular diseases remain a leading cause of global mortality. Potassium channel openers (PCOs) offer cardioprotective effects through modulation of cellular excitability and mitochondrial function. This narrative review critically evaluates mechanistic and clinical evidence published between 2000 and 2024, focusing on nicorandil and diazoxide in ischemia-reperfusion injury and cardiotoxicity. We examine mitochondrial ATP-sensitive potassium (mitoKATP) and large-conductance calcium-activated potassium (BKCa) channels, their roles in mitochondrial energetics and redox homeostasis, and their interplay with inhibition of mitochondrial permeability transition pore opening. Clinical contexts include cardioplegic arrest, myocardial infarction, and chemotherapy-induced cardiotoxicity. PCOs, particularly nicorandil, combine mitochondrial protection with hemodynamic benefits, with evidence supporting reductions in major adverse cardiovascular events and preservation of mitochondrial integrity. However, routine clinical integration remains constrained by translational gaps, inconsistent electrophysiological effects, and dose-limiting adverse events, including hypotension. Future development should prioritize mitochondrial channel subtype selectivity, particularly targeted mitoKATP and BKCa modulation, alongside well-designed randomized controlled trials to establish clinical efficacy and safety. These advances may strengthen the role of PCOs in cardiovascular medicine while minimizing systemic vascular adverse effects.</p>","PeriodicalId":12589,"journal":{"name":"Future cardiology","volume":" ","pages":"1-14"},"PeriodicalIF":1.1,"publicationDate":"2026-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149417392","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of a novel transseptal puncture device for use in cardiac procedures requiring left atrial access. 评估一种新型的经间隔穿刺装置用于需要左心房通道的心脏手术。
IF 1.1
Future cardiology Pub Date : 2026-11-14 DOI: 10.1080/14796678.2026.2755225
Rachael W Quinn, Gagan D Singh, Adrian Ebner, Chetan Pasrija, AlleaBelle Bradshaw, Christopher Rumer, David Mester, Cameron Purcell, James S Gammie
{"title":"Evaluation of a novel transseptal puncture device for use in cardiac procedures requiring left atrial access.","authors":"Rachael W Quinn, Gagan D Singh, Adrian Ebner, Chetan Pasrija, AlleaBelle Bradshaw, Christopher Rumer, David Mester, Cameron Purcell, James S Gammie","doi":"10.1080/14796678.2026.2755225","DOIUrl":"https://doi.org/10.1080/14796678.2026.2755225","url":null,"abstract":"<p><p>Transseptal puncture (TSP) is the first step in percutaneous left-heart interventions including atrial fibrillation ablation, left atrial appendage occlusion, and percutaneous mitral valve repair/replacement. Current TSP techniques remain limited by suboptimal imaging visualization, lack of precise control over puncture sites, and a steep learning curve. The Protaryx transseptal puncture device was designed to address these limitations by incorporating a novel atraumatic highly echogenic deployable and retractable nitinol mesh end effector mounted on an extendable catheter. The key advantages of the Protaryx TSP device are the maneuverability of the extendable catheter and the visibility of the end effector that combine to enable precise targeting of the fossa ovalis during TSP. Here, we provide an overview of challenges with transseptal puncture, an overview of the Protaryx device, and early clinical evidence. This includes results of the 5-patient prospective non-randomized observational first-in-human experience with the Protaryx TSP catheter. This study demonstrated early feasibility and safety, with rapid on-target puncture of the fossa ovalis, zero adverse events, and 100% success of structural heart interventions following TSP. The United States Food and Drug Administration (FDA) approval of the Protaryx device has increased options for interventional cardiologists and electrophysiologists seeking to streamline left-sided structural heart intervention.</p>","PeriodicalId":12589,"journal":{"name":"Future cardiology","volume":" ","pages":"1-10"},"PeriodicalIF":1.1,"publicationDate":"2026-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149404640","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The prognostic value of the triglyceride-glucose index in individuals with hypertension. 甘油三酯-葡萄糖指数在高血压患者中的预后价值。
IF 1.1
Future cardiology Pub Date : 2026-11-14 DOI: 10.1080/14796678.2026.2762672
Lanfranco D'Elia, Ferruccio Galletti, Ersilia La Fata, Claudia Ciampa, Vittorio Salvatore, Saverio Stranges
{"title":"The prognostic value of the triglyceride-glucose index in individuals with hypertension.","authors":"Lanfranco D'Elia, Ferruccio Galletti, Ersilia La Fata, Claudia Ciampa, Vittorio Salvatore, Saverio Stranges","doi":"10.1080/14796678.2026.2762672","DOIUrl":"https://doi.org/10.1080/14796678.2026.2762672","url":null,"abstract":"<p><p>Hypertension frequently coexists with metabolic abnormalities that contribute to cardiovascular risk. The triglyceride-glucose (TyG) index is a simple surrogate marker of insulin resistance that may also reflect early cardiometabolic and cardiovascular vulnerability. This narrative review examines the prognostic relevance of TyG for all-cause mortality, cardiovascular mortality, and fatal or non-fatal cardiovascular events in hypertension. PubMed, Embase, and the Cochrane Library were searched through 5 October 2026, without date or language restrictions. Evidence from primary hypertensive cohorts generally supports associations between higher TyG and adverse outcomes, although their magnitude and shape vary, with both linear and nonlinear patterns reported. Findings are most consistent among hypertensive patients with diabetes, whereas results from other high-risk settings and hypertension-specific subgroup analyses are more heterogeneous. Differences in TyG calculation, modeling, glycemic status, clinical settings, and overlapping cohorts complicate comparisons across studies. Overall, TyG may represent a readily available, low-cost marker of early cardiometabolic and cardiovascular vulnerability, beyond its role as a surrogate of insulin resistance, with potential to refine cardiovascular risk stratification in hypertension. Further prospective validation should establish its incremental predictive value beyond conventional cardiovascular risk factors and established risk scores.</p>","PeriodicalId":12589,"journal":{"name":"Future cardiology","volume":" ","pages":"1-11"},"PeriodicalIF":1.1,"publicationDate":"2026-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149404641","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical effectiveness of outpatient cardiac rehabilitation according to myocardial injury after acute myocardial infarction. 急性心肌梗死后根据心肌损伤进行门诊心脏康复的临床效果分析。
IF 1.1
Future cardiology Pub Date : 2026-11-13 DOI: 10.1080/14796678.2026.2762671
Takashi Kataoka, Ryoga Kawabata, Kazuki Watarai, Satoshi Terashima, Shinichiro Takeda, Shun Matsunaga, Kunihiko Takahara, Kumiko Mamiya, Kazuhiro Harada, Tomoyuki Nagao, Norihiro Shinoda, Ken Harada, Toyoaki Murohara
{"title":"Clinical effectiveness of outpatient cardiac rehabilitation according to myocardial injury after acute myocardial infarction.","authors":"Takashi Kataoka, Ryoga Kawabata, Kazuki Watarai, Satoshi Terashima, Shinichiro Takeda, Shun Matsunaga, Kunihiko Takahara, Kumiko Mamiya, Kazuhiro Harada, Tomoyuki Nagao, Norihiro Shinoda, Ken Harada, Toyoaki Murohara","doi":"10.1080/14796678.2026.2762671","DOIUrl":"https://doi.org/10.1080/14796678.2026.2762671","url":null,"abstract":"<p><strong>Background: </strong>Cardiac rehabilitation (CR) is recommended after acute myocardial infarction (AMI), but whether its benefit differs by infarct size remains uncertain. We examined whether the effectiveness of CR varies according to peak creatine phosphokinase (CPK), a surrogate marker of myocardial injury.</p><p><strong>Methods: </strong>We retrospectively analyzed 535 AMI survivors who underwent emergency percutaneous coronary intervention between January 2015 and November 2025. Patients were divided into CR and non‑CR groups. The primary endpoint was major adverse cardiovascular events (MACE), defined as all‑cause death, recurrent myocardial infarction, or heart failure hospitalization. Patients were stratified by peak CPK (<2000 vs. ≥2000 U/L), and Kaplan-Meier and Cox analyses were performed.</p><p><strong>Results: </strong>Among 535 patients, 165 (31%) participated in CR. CR was associated with lower MACE incidence in the overall cohort (hazard ratio [HR] 0.23, 95% confidence interval [CI] 0.14-0.81, <i>p</i> = 0.01). In the high‑CPK subgroup, CR significantly reduced MACE (HR 0.21, 95% CI 0.04-0.96, <i>p</i> = 0.04), whereas the low‑CPK subgroup showed only nonsignificant trend. Similar findings were observed in patients who underwent cardiopulmonary exercise testing.</p><p><strong>Conclusions: </strong>Outpatient CR was associated with improved outcomes after AMI, with greater benefit in patients with higher peak CPK. Myocardial injury severity may help identify patients most likely to benefit from CR.</p>","PeriodicalId":12589,"journal":{"name":"Future cardiology","volume":" ","pages":"1-11"},"PeriodicalIF":1.1,"publicationDate":"2026-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149404639","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preventing pacing-induced cardiomyopathy through early risk stratification. 通过早期风险分层预防起搏性心肌病。
IF 1.1
Future cardiology Pub Date : 2026-11-04 DOI: 10.1080/14796678.2026.2756211
Ergi Duli, Souzan Yacob, Maria Luz Garagiola, Jose Llorente Rodríguez, Sanoj Chacko, Adrian Baranchuk
{"title":"Preventing pacing-induced cardiomyopathy through early risk stratification.","authors":"Ergi Duli, Souzan Yacob, Maria Luz Garagiola, Jose Llorente Rodríguez, Sanoj Chacko, Adrian Baranchuk","doi":"10.1080/14796678.2026.2756211","DOIUrl":"https://doi.org/10.1080/14796678.2026.2756211","url":null,"abstract":"","PeriodicalId":12589,"journal":{"name":"Future cardiology","volume":" ","pages":"1-3"},"PeriodicalIF":1.1,"publicationDate":"2026-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149320313","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction. 修正。
IF 1.1
Future cardiology Pub Date : 2026-10-29 DOI: 10.1080/14796678.2026.2756805
{"title":"Correction.","authors":"","doi":"10.1080/14796678.2026.2756805","DOIUrl":"https://doi.org/10.1080/14796678.2026.2756805","url":null,"abstract":"","PeriodicalId":12589,"journal":{"name":"Future cardiology","volume":" ","pages":"1"},"PeriodicalIF":1.1,"publicationDate":"2026-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149296579","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The emerging role of orbital atherectomy in the management of heavily calcified lesions in percutaneous coronary intervention. 眶动脉粥样硬化切除术在经皮冠状动脉介入治疗严重钙化病变中的新作用。
IF 1.1
Future cardiology Pub Date : 2026-10-21 DOI: 10.1080/14796678.2026.2752749
Ayman Helal, F Aaysha Cader, Simon Hetherington, Nasir Ahmad, Javed Ehtisham, Kai Hogrefe, Prashanth Raju, Naeem Shaukat, Mohsin Farooq
{"title":"The emerging role of orbital atherectomy in the management of heavily calcified lesions in percutaneous coronary intervention.","authors":"Ayman Helal, F Aaysha Cader, Simon Hetherington, Nasir Ahmad, Javed Ehtisham, Kai Hogrefe, Prashanth Raju, Naeem Shaukat, Mohsin Farooq","doi":"10.1080/14796678.2026.2752749","DOIUrl":"https://doi.org/10.1080/14796678.2026.2752749","url":null,"abstract":"<p><p>Severe coronary calcification is a challenge to optimal percutaneous coronary intervention (PCI). Adequate lesion preparation is essential to achieve appropriate stent expansion and improve long-term outcomes. Recently, orbital atherectomy (OA) has emerged as an important tool for calcium modification, offering a unique mechanism of action based on centrifugal sanding and differential cutting. This review summarizes the contemporary evidence supporting OA in heavily calcified coronary disease, compares it to other established calcium modification strategies, and highlights practical scenarios where OA offers distinctive advantages. Several calcium algorithms exist, detailing start points according to balloon crossability and stepwise escalation guided by intravascular imaging. Orbital atherectomy has recently become available across centers in Europe and the United Kingdom, providing an alternative calcium‑debulking toolkit that is of particular use in some indications, with advantages over other techniques. In this review, we look at the emerging role of OA in calcified lesions, with a critical appraisal of the data and highlighting its utility drawing examples from the published literature and our center's experience.</p>","PeriodicalId":12589,"journal":{"name":"Future cardiology","volume":" ","pages":"1-6"},"PeriodicalIF":1.1,"publicationDate":"2026-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149231019","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Current challenges in the diagnosis of arrhythmia-induced cardiomyopathy. 心律失常性心肌病诊断的当前挑战。
IF 1.1
Future cardiology Pub Date : 2026-10-03 DOI: 10.1080/14796678.2026.2739186
Jörg Yogarajah, Samuel Sossalla
{"title":"Current challenges in the diagnosis of arrhythmia-induced cardiomyopathy.","authors":"Jörg Yogarajah, Samuel Sossalla","doi":"10.1080/14796678.2026.2739186","DOIUrl":"https://doi.org/10.1080/14796678.2026.2739186","url":null,"abstract":"","PeriodicalId":12589,"journal":{"name":"Future cardiology","volume":" ","pages":"1-4"},"PeriodicalIF":1.1,"publicationDate":"2026-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149108125","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Physical activity and quality of life in patients with hypertrophic cardiomyopathy in Japan: a quantitative study. 日本肥厚性心肌病患者的身体活动和生活质量:一项定量研究。
IF 1.1
Future cardiology Pub Date : 2026-10-01 Epub Date: 2026-10-13 DOI: 10.1080/14796678.2026.2745404
Hiroaki Kitaoka, Toru Kubo, Makio Torigoe, Yuika Ikeda, Kanako Shimoura, Shintaro Suo, Ryohei Takeda, Yuichiro Maekawa
{"title":"Physical activity and quality of life in patients with hypertrophic cardiomyopathy in Japan: a quantitative study.","authors":"Hiroaki Kitaoka, Toru Kubo, Makio Torigoe, Yuika Ikeda, Kanako Shimoura, Shintaro Suo, Ryohei Takeda, Yuichiro Maekawa","doi":"10.1080/14796678.2026.2745404","DOIUrl":"10.1080/14796678.2026.2745404","url":null,"abstract":"<p><strong>Aim: </strong>To describe the burden of hypertrophic cardiomyopathy (HCM) using patient-reported outcome tools and a study-specific questionnaire.</p><p><strong>Patients and methods: </strong>This two-phase, cross-sectional, non-interventional, observational study (qualitative [previous] and quantitative [current]) included adults with HCM and New York Heart Association functional classification 2/3 recruited from healthcare facilities across Japan. The International Physical Activity Questionnaire (IPAQ), Kansas City Cardiomyopathy Questionnaire (KCCQ), Hypertrophic Cardiomyopathy Symptom Questionnaire (HCMSQ), and Hospital Anxiety and Depression Scale (HADS) were used alongside a questionnaire developed using the qualitative findings.</p><p><strong>Results: </strong>The analysis included 120 patients (mean age, 59.1 ± 16.3 years; 55.5% [66/120] male), 60 each with non-obstructive and obstructive HCM. Patients with (vs. without) lifestyle changes had lower median IPAQ score (495.0 [363.0-1803.5] vs. 990.0 [369.4-2295.0], <i>p</i> = 0.159) and KCCQ - Clinical Summary Score (81.3 [65.6-90.7] vs. 92.0 [81.4-97.9], <i>p</i> < 0.001), and higher HADS-Depression (5.0 [3.0-8.0] vs. 2.0 [1.0-6.0], <i>p</i> = 0.001) and HCMSQ-shortness of breath (5.0 [2.0-6.0] vs. 3.0 [0.0-4.5], <i>p</i> < 0.001) scores. Most patients (83.9%) noticed HCM symptoms, and some patients attributed symptoms to causes other than HCM. Most patients (89.0%) told others about their HCM. Primary care physicians were the main information source (99.2%).</p><p><strong>Conclusions: </strong>In this quantitative analysis, HCM affected patients' lifestyles and physical activity.</p><p><strong>Clinical trial registration: </strong>NCT06181617 (ClinicalTrials.gov).</p>","PeriodicalId":12589,"journal":{"name":"Future cardiology","volume":" ","pages":"991-1002"},"PeriodicalIF":1.1,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13733136/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149181100","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sex-informed interpretation of coronary artery calcium in primary prevention. 冠状动脉钙化在初级预防中的性别解释。
IF 1.1
Future cardiology Pub Date : 2026-10-01 Epub Date: 2026-10-06 DOI: 10.1080/14796678.2026.2742753
Julien Rosencher, Thiziri Si-Moussi, Domenico Mario Giamundo, Dan Atar, Roger S Blumenthal, Pierre Sabouret
{"title":"Sex-informed interpretation of coronary artery calcium in primary prevention.","authors":"Julien Rosencher, Thiziri Si-Moussi, Domenico Mario Giamundo, Dan Atar, Roger S Blumenthal, Pierre Sabouret","doi":"10.1080/14796678.2026.2742753","DOIUrl":"10.1080/14796678.2026.2742753","url":null,"abstract":"<p><p>Coronary artery calcium (CAC) scoring is selectively used to refine cardiovascular risk assessment in primary prevention, but interpretation still relies largely on absolute thresholds applied similarly to women and men. This approach may overlook relevant sex-related differences in coronary atherosclerosis. Women tend to develop detectable CAC later in life and have lower absolute CAC values for a given age, while sex-related differences in coronary plaque composition may not be fully captured by calcium scoring alone. Consequently, a low absolute CAC score may still represent a high age- and sex-specific percentile in women. Traditional risk algorithms and CAC-based strategies also do not systematically account for female-specific risk enhancers, including hypertensive disorders of pregnancy, gestational diabetes, premature menopause, and polycystic ovary syndrome. Relevant literature was identified through a PubMed search from database inception to September 2026. This Perspective examines sex-related differences in CAC distribution and prognosis and discusses how absolute CAC scores, demographic percentiles, and female-specific risk enhancers can inform preventive care. We propose integrating these measures while retaining established absolute CAC categories. The clinical value of distinct numerical treatment thresholds for women and men requires prospective evaluation.</p>","PeriodicalId":12589,"journal":{"name":"Future cardiology","volume":" ","pages":"1039-1046"},"PeriodicalIF":1.1,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13750184/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149108158","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书